New frontiers in the neuropsychopharmacology of mental illness
In recent years, mental illnesses have become recognized as a huge emotional and financial burden to the individual, their relatives and society at large. Stress-related and mood disorders as well as psychoactive substance abuse are among the disorders associated with most disability in high income...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Online |
| Reo: | Ingarihi |
| I whakaputaina: |
Frontiers Media SA
2021
|
| Ngā marau: | |
| Urunga tuihono: | 17797 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
| _version_ | 1869517604665688064 |
|---|---|
| author | Laurence Lanfumey Maarten Van Den Buuse Thibault Renoir |
| author_browse | Laurence Lanfumey Maarten Van Den Buuse Thibault Renoir |
| author_facet | Laurence Lanfumey Maarten Van Den Buuse Thibault Renoir |
| author_sort | Laurence Lanfumey |
| collection | Directory of Open Access Books |
| description | In recent years, mental illnesses have become recognized as a huge emotional and financial burden to the individual, their relatives and society at large. Stress-related and mood disorders as well as psychoactive substance abuse are among the disorders associated with most disability in high income countries. Suicide, which is often attributed to some underlying mental disorders, is a leading cause of death among teenagers and young adults. At the same time, mental disorders pose some of the toughest challenges in neuroscience research. There are many different categories of mental disorder as defined and classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the International Statistical Classification of Diseases 10th Revision (ICD-10). Despite the ongoing improvements of those widely used manuals, the validity and reliability of their diagnoses remain a constant debate. However, it has now become accepted by the scientific community that mental disorders can arise from multiple sources. In that regard, both clinical and animal studies looking at gene-environment interactions have helped to better understand the mechanisms involved in the pathophysiology as well as the discovery of treatments for mental disorders. This Research Topic aims to cover recent progress in research studying how genetic make-up and environmental factors (such as stress paradigm or pharmacological treatment) can contribute to the development of mental disorders such as anxiety, depression, and schizophrenia. This Research Topic also seeks to highlight studies looking at affective-like disorders following the intake of drugs of abuse. We also welcome all research articles, review papers, brief communications, and commentary on topics related to the broad field of Neuropsychopharmacology. |
| format | Online |
| id | doab-20.500.12854ir-54578 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2021 |
| publishDateRange | 2021 |
| publishDateSort | 2021 |
| publisher | Frontiers Media SA |
| publisherStr | Frontiers Media SA |
| record_format | ojs |
| spelling | doab-20.500.12854ir-545782024-04-01T14:14:51Z New frontiers in the neuropsychopharmacology of mental illness Laurence Lanfumey Maarten Van Den Buuse Thibault Renoir RM1-950 Q1-390 Addiction gene Schizophrenia Depression Anxiety Mood Disorders thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology In recent years, mental illnesses have become recognized as a huge emotional and financial burden to the individual, their relatives and society at large. Stress-related and mood disorders as well as psychoactive substance abuse are among the disorders associated with most disability in high income countries. Suicide, which is often attributed to some underlying mental disorders, is a leading cause of death among teenagers and young adults. At the same time, mental disorders pose some of the toughest challenges in neuroscience research. There are many different categories of mental disorder as defined and classified by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and the International Statistical Classification of Diseases 10th Revision (ICD-10). Despite the ongoing improvements of those widely used manuals, the validity and reliability of their diagnoses remain a constant debate. However, it has now become accepted by the scientific community that mental disorders can arise from multiple sources. In that regard, both clinical and animal studies looking at gene-environment interactions have helped to better understand the mechanisms involved in the pathophysiology as well as the discovery of treatments for mental disorders. This Research Topic aims to cover recent progress in research studying how genetic make-up and environmental factors (such as stress paradigm or pharmacological treatment) can contribute to the development of mental disorders such as anxiety, depression, and schizophrenia. This Research Topic also seeks to highlight studies looking at affective-like disorders following the intake of drugs of abuse. We also welcome all research articles, review papers, brief communications, and commentary on topics related to the broad field of Neuropsychopharmacology. 2021-02-11T20:54:28Z 2021-02-11T20:54:28Z 2015-12-10 11:59:06 2015 book 17797 16648714 9782889194049 https://directory.doabooks.org/handle/20.500.12854/54578 eng Frontiers Research Topics image/jpeg Attribution 4.0 International http://www.frontiersin.org/books/New_frontiers_in_the_neuropsychopharmacology_of_mental_illness/425 http://journal.frontiersin.org/researchtopic/958/new-frontiers-in-the-neuropsychopharmacology-of-mental-illness Frontiers Media SA 10.3389/978-2-88919-404-9 10.3389/978-2-88919-404-9 bf5ce210-e72e-4860-ba9b-c305640ff3ae 9782889194049 254 open access |
| spellingShingle | RM1-950 Q1-390 Addiction gene Schizophrenia Depression Anxiety Mood Disorders thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology Laurence Lanfumey Maarten Van Den Buuse Thibault Renoir New frontiers in the neuropsychopharmacology of mental illness |
| title | New frontiers in the neuropsychopharmacology of mental illness |
| title_full | New frontiers in the neuropsychopharmacology of mental illness |
| title_fullStr | New frontiers in the neuropsychopharmacology of mental illness |
| title_full_unstemmed | New frontiers in the neuropsychopharmacology of mental illness |
| title_short | New frontiers in the neuropsychopharmacology of mental illness |
| title_sort | new frontiers in the neuropsychopharmacology of mental illness |
| topic | RM1-950 Q1-390 Addiction gene Schizophrenia Depression Anxiety Mood Disorders thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| topic_facet | RM1-950 Q1-390 Addiction gene Schizophrenia Depression Anxiety Mood Disorders thema EDItEUR::M Medicine and Nursing::MK Medical specialties, branches of medicine::MKG Pharmacology |
| url | 17797 |
| work_keys_str_mv | AT laurencelanfumey newfrontiersintheneuropsychopharmacologyofmentalillness AT maartenvandenbuuse newfrontiersintheneuropsychopharmacologyofmentalillness AT thibaultrenoir newfrontiersintheneuropsychopharmacologyofmentalillness |